These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 32957904)
21. Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. Bhat AA; Yousuf P; Wani NA; Rizwan A; Chauhan SS; Siddiqi MA; Bedognetti D; El-Rifai W; Frenneaux MP; Batra SK; Haris M; Macha MA Signal Transduct Target Ther; 2021 Jan; 6(1):12. PubMed ID: 33436555 [TBL] [Abstract][Full Text] [Related]
22. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells. Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598 [TBL] [Abstract][Full Text] [Related]
23. CD44(high) /ALDH1(high) head and neck squamous cell carcinoma cells exhibit mesenchymal characteristics and GSK3β-dependent cancer stem cell properties. Seino S; Shigeishi H; Hashikata M; Higashikawa K; Tobiume K; Uetsuki R; Ishida Y; Sasaki K; Naruse T; Rahman MZ; Ono S; Simasue H; Ohta K; Sugiyama M; Takechi M J Oral Pathol Med; 2016 Mar; 45(3):180-8. PubMed ID: 26399460 [TBL] [Abstract][Full Text] [Related]
24. CD44-Targeted Magnetic Nanoparticles Kill Head And Neck Squamous Cell Carcinoma Stem Cells In An Alternating Magnetic Field. Su Z; Liu D; Chen L; Zhang J; Ru L; Chen Z; Gao Z; Wang X Int J Nanomedicine; 2019; 14():7549-7560. PubMed ID: 31571863 [TBL] [Abstract][Full Text] [Related]
25. Distinct roles of PIK3CA in the enrichment and maintenance of cancer stem cells in head and neck squamous cell carcinoma. Chen X; Cao Y; Sedhom W; Lu L; Liu Y; Wang H; Oka M; Bornstein S; Said S; Song J; Lu SL Mol Oncol; 2020 Jan; 14(1):139-158. PubMed ID: 31600013 [TBL] [Abstract][Full Text] [Related]
26. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma. Roy S; Roy S; Kar M; Padhi S; Saha A; Anuja K; Banerjee B J Oral Pathol Med; 2018 May; 47(5):492-501. PubMed ID: 29575240 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. Bourguignon LY; Wong G; Shiina M J Biol Chem; 2016 May; 291(20):10571-85. PubMed ID: 27002147 [TBL] [Abstract][Full Text] [Related]
28. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Kaseb HO; Fohrer-Ting H; Lewis DW; Lagasse E; Gollin SM Exp Cell Res; 2016 Oct; 348(1):75-86. PubMed ID: 27619333 [TBL] [Abstract][Full Text] [Related]
29. The Role of Hedgehog Signaling Pathway in Head and Neck Squamous Cell Carcinoma. Cierpikowski P; Leszczyszyn A; Bar J Cells; 2023 Aug; 12(16):. PubMed ID: 37626893 [TBL] [Abstract][Full Text] [Related]
30. Immunotherapeutics for head and neck squamous cell carcinoma stem cells. Qian X; Leonard F; Wenhao Y; Sudhoff H; Hoffmann TK; Ferrone S; Kaufmann AM; Albers AE HNO; 2020 Feb; 68(2):94-99. PubMed ID: 31996933 [TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells enrichment with surface markers CD271 and CD44 in human head and neck squamous cell carcinomas. Elkashty OA; Abu Elghanam G; Su X; Liu Y; Chauvin PJ; Tran SD Carcinogenesis; 2020 Jun; 41(4):458-466. PubMed ID: 31742606 [TBL] [Abstract][Full Text] [Related]
32. Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma. Moon JH; Rho YS; Lee SH; Koo BS; Lee HJ; Do SI; Cho JH; Eun YG; Park MW; Shin HA; Lim YC Oral Oncol; 2019 Sep; 96():34-41. PubMed ID: 31422211 [TBL] [Abstract][Full Text] [Related]
33. The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma. Li J; Li Z; Wu Y; Wang Y; Wang D; Zhang W; Yuan H; Ye J; Song X; Yang J; Jiang H; Cheng J Cell Death Dis; 2019 Aug; 10(8):603. PubMed ID: 31399556 [TBL] [Abstract][Full Text] [Related]
34. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells. Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963 [TBL] [Abstract][Full Text] [Related]
35. Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus. Wang H; Zhao Q; Zhang Y; Zhang Q; Zheng Z; Liu S; Liu Z; Meng L; Xin Y; Jiang X Front Immunol; 2021; 12():652054. PubMed ID: 34305889 [TBL] [Abstract][Full Text] [Related]
36. Combining radiation to EGFR and Bcl-2 blockade: a new approach to target cancer stem cells in head and neck squamous cell carcinoma. Guy JB; Espenel S; Louati S; Gauthier A; Garcia MA; Vial N; Malésys C; Ardail D; Alphonse G; Wozny AS; Rodriguez-Lafrasse C; Magné N J Cancer Res Clin Oncol; 2021 Jul; 147(7):1905-1916. PubMed ID: 33791846 [TBL] [Abstract][Full Text] [Related]
37. Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Reid P; Marcu LG; Olver I; Moghaddasi L; Staudacher AH; Bezak E Radiother Oncol; 2019 Jun; 135():1-12. PubMed ID: 31015153 [TBL] [Abstract][Full Text] [Related]
38. Biology and immunology of cancer stem(-like) cells in head and neck cancer. Qian X; Ma C; Nie X; Lu J; Lenarz M; Kaufmann AM; Albers AE Crit Rev Oncol Hematol; 2015 Sep; 95(3):337-45. PubMed ID: 25907739 [TBL] [Abstract][Full Text] [Related]
39. SMURF1 silencing diminishes a CD44-high cancer stem cell-like population in head and neck squamous cell carcinoma. Khammanivong A; Gopalakrishnan R; Dickerson EB Mol Cancer; 2014 Dec; 13():260. PubMed ID: 25471937 [TBL] [Abstract][Full Text] [Related]
40. G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Liu S; Ye D; Guo W; Yu W; He Y; Hu J; Wang Y; Zhang L; Liao Y; Song H; Zhong S; Xu D; Yin H; Sun B; Wang X; Liu J; Wu Y; Zhou BP; Zhang Z; Deng J Oncotarget; 2015 Mar; 6(9):6887-901. PubMed ID: 25749385 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]